“Natalizumab (Tysabri) in Multiple Sclerosis Patients”. Farmeconomia. Health Economics and Therapeutic Pathways 9, no. 2 (June 15, 2008): 109–114. Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/222.